Related references
Note: Only part of the references are listed.Smaller Cornu Ammonis 2-3/Dentate Gyrus Volumes and Elevated Cortisol in Multiple Sclerosis Patients with Depressive Symptoms
Stefan M. Gold et al.
BIOLOGICAL PSYCHIATRY (2010)
Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla
M. Inglese et al.
BRAIN (2010)
Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis-A longitudinal MRI study
Kerstin Bendfeldt et al.
BRAIN RESEARCH (2010)
Structural and functional magnetic resonance imaging correlates of motor network dysfunction in primary progressive multiple sclerosis
Antonia Ceccarelli et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Spatiotemporal Distribution Pattern of White Matter Lesion Volumes and Their Association With Regional Grey Matter Volume Reductions in Relapsing-Remitting Multiple Sclerosis
Kerstin Bendfeldt et al.
HUMAN BRAIN MAPPING (2010)
Intercenter Differences in Diffusion Tensor MRI Acquisition
Elisabetta Pagani et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
The association between California Verbal Learning Test performance and fibre impairment in multiple sclerosis: evidence from diffusion tensor imaging
Frauke Fink et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study
V. M. Anderson et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Latitudinal variation in incidence and type of first central nervous system demyelinating events
Bruce V. Taylor et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Basal ganglia and frontal/parietal cortical atrophy is associated with fatigue in relapsing-remitting multiple sclerosis
Massimiliano Calabrese et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
T helper type 1 and 17 cells determine efficacy of interferon-β in multiple sclerosis and experimental encephalomyelitis
Robert C. Axtell et al.
NATURE MEDICINE (2010)
Breakthrough disease during interferon-β therapy in MS No signs of impaired biologic response
D. Hesse et al.
NEUROLOGY (2010)
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis
M. Calabrese et al.
NEUROLOGY (2010)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole
R. T. Naismith et al.
NEUROLOGY (2010)
MRI criteria for MS in patients with clinically isolated syndromes
X. Montalban et al.
NEUROLOGY (2010)
Magnetic Resonance Imaging as a Potential Surrogate for Relapses in Multiple Sclerosis: A Meta-analytic Approach
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2009)
Substantial Archaeocortical Atrophy and Neuronal Loss in Multiple Sclerosis
Dimitrios Papadopoulos et al.
BRAIN PATHOLOGY (2009)
Advances in the molecular imaging of multiple sclerosis
Paul M. Matthews et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2009)
Characterizing Iron Deposition in Multiple Sclerosis Lesions Using Susceptibility Weighted Imaging
E. Mark Haacke et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2009)
New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetate
D. Cadavid et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Incidence and factors associated with treatment failure in the CLIMB multiple sclerosis cohort study
S. A. Gauthier et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
A sensitive, noise-resistant method for identifying focal demyelination and remyelination in patients with multiple sclerosis via voxel-wise changes in magnetization transfer ratio
Michael Dwyer et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Early onset multiple sclerosis: The role of gender
Mar Tintore et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Gender differences in multiple sclerosis: Cytokines and vitamin D
M. J. Eikelenboom et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Alemtuzumab versus interferon beta-1a: implications for pathology and trial design
Henry F. McFarland
LANCET NEUROLOGY (2009)
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials
Frederik Barkhof et al.
NATURE REVIEWS NEUROLOGY (2009)
Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis
Balasrinivasa R. Sajja et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2009)
Incidental MRI anomalies suggestive of multiple sclerosis The radiologically isolated syndrome
D. T. Okuda et al.
NEUROLOGY (2009)
The present efficacy of multiple sclerosis therapeutics Is the new 66% just the old 33%?
Eric C. Klawiter et al.
NEUROLOGY (2009)
In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI
C. Mainero et al.
NEUROLOGY (2009)
Gray matter atrophy in multiple sclerosis: A longitudinal study
Elizabeth Fisher et al.
ANNALS OF NEUROLOGY (2008)
Gray matter atrophy is related to long-term disability in multiple sclerosis
Leonora K. Fisniku et al.
ANNALS OF NEUROLOGY (2008)
Predicting Clinical Progression in Multiple Sclerosis With the Magnetic Resonance Disease Severity Scale
Rohit Bakshi et al.
ARCHIVES OF NEUROLOGY (2008)
Regional hippocampal atrophy in multiple sclerosis
N. L. Sicotte et al.
BRAIN (2008)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Efficacy of disease-modifying therapies in relapsing remitting multiple sclerosis: A systematic comparison
Mark S. Freedman et al.
EUROPEAN NEUROLOGY (2008)
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile
C. Lebrun et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis
Ij van den Elskamp et al.
MULTIPLE SCLEROSIS (2008)
Canadian treatment optimization recommendations (TOR) as a predictor of disease breakthrough in patients with multiple sclerosis treated with interferon β-1a: analysis of the PRISMS study
M. S. Freedman et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Differential diagnosis of suspected multiple sclerosis: a consensus approach
D. H. Miller et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Gleaning Multicomponent T1 and T2 Information From Steady-State Imaging Data
Sean C. L. Deoni et al.
MAGNETIC RESONANCE IN MEDICINE (2008)
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis
R. Zivadinov et al.
NEUROLOGY (2008)
Temporal trends in the incidence of multiple sclerosis
Alvaro Alonso et al.
NEUROLOGY (2008)
Guidelines for using proton MR spectroscopy in multicenter clinical MS studies
N. De Stefano et al.
NEUROLOGY (2007)
Thalamic atrophy and cognition in multiple sclerosis
M. K. Houtchens et al.
NEUROLOGY (2007)
Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology
Roberta Magliozzi et al.
BRAIN (2007)
Extensive hippocampal demyelination in multiple sclerosis
Jeroen J. G. Geurts et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2007)
Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis
Dean M. Wingerchuk et al.
CURRENT OPINION IN NEUROLOGY (2007)
Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology
C. Laule et al.
MULTIPLE SCLEROSIS (2006)
MRI and the diagnosis of multiple sclerosis: expanding the concept of no better explanation
Arnaud Charil et al.
LANCET NEUROLOGY (2006)
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Every-other-clay interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NAb
P Barbero et al.
MULTIPLE SCLEROSIS JOURNAL (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Effects of interferon beta-1b on black holes in multiple sclerosis over a 6-year period with monthly evaluations
F Bagnato et al.
ARCHIVES OF NEUROLOGY (2005)
Cortical demyelination and diffuse white matter injury in multiple sclerosis
A Kutzelnigg et al.
BRAIN (2005)
Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3 T
R Srinivasan et al.
BRAIN (2005)
Rate of brain atrophy in relapsing MS decreases during treatment with IFNβ-1a
M Hardmeier et al.
NEUROLOGY (2005)
Measurement error of two different techniques for brain atrophy assessment in multiple sclerosis
MP Sormani et al.
NEUROLOGY (2004)
Interferon-β-1b slows progression of atrophy in RRMS -: Three-year follow-up in NAb- and NAb+ patients
JA Frank et al.
NEUROLOGY (2004)
Interferon beta-1b in secondary progressive MS - A combined analysis of the two trials
L Kappos et al.
NEUROLOGY (2004)
An open-label safety and drug interaction study of natalizumab (Antegren (TM)) in combination with interferon-beta (Avonex (R)) in patients with multiple sclerosis
TL Vollmer et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years
F Bagnato et al.
BRAIN (2003)
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Thalamic neurodegeneration in relapsing-remitting multiple sclerosis
M Wylezinska et al.
NEUROLOGY (2003)
Randomized, comparative study of interferon β-1a treatment regimens in MS -: The EVIDENCE trial
H Panitch et al.
NEUROLOGY (2002)
Eight-year follow-up study of brain atrophy in patients with MS
E Fisher et al.
NEUROLOGY (2002)
Thalamic neurodegeneration in multiple sclerosis
A Cifelli et al.
ANNALS OF NEUROLOGY (2002)
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
L Durelli et al.
LANCET (2002)
Short-term brain volume change in relapsing-remitting multiple sclerosis - Effect of glatiramer acetate and implications
M Rovaris et al.
BRAIN (2001)
Glatiramer acetate reduces the proportion of new MS lesions evolving into black holes
M Filippi et al.
NEUROLOGY (2001)
T1 hypointense lesions in secondary progressive multiple sclerosis:: effect of interferon beta-1b treatment
F Barkhof et al.
BRAIN (2001)
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis
WI McDonald et al.
ANNALS OF NEUROLOGY (2001)
SPG15, a new locus for autosomal recessive complicated HSP on chromosome 14q
CA Hughes et al.
NEUROLOGY (2001)
Medical progress: Multiple sclerosis.
JH Noseworthy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS - Quantitative MR assessment
Y Ge et al.
NEUROLOGY (2000)
Effect of interferon β-1b in MS -: Assessment of annual accumulation of PD/T2 activity on MRI
GJ Zhao et al.
NEUROLOGY (2000)
Share Paper
